Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03924934 · ClinicalTrials.gov registry record
Community-associated Highly-Resistant Enterobacterales
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 2,172
- Enrollment target
NCT03924934 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2,172 participants.
The verdict
NCT03924934 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 2,172 participants
- Enrollment target
Study Summary
This is a prospective multi-center study. Bacterial isolates from hospitalized patients with CA-HRE will be compared to those from hospitalized patients with healthcare-associated HRE (HA-HRE). In addition, community spread of CRE will be determined.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,172 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2024-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03924934
The ClinicalTrials.gov registry entry for NCT03924934 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03924934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03924934 about?
NCT03924934 is a clinical study titled "Community-associated Highly-Resistant Enterobacterales". This is a prospective multi-center study. Bacterial isolates from hospitalized patients with CA-HRE will be compared to those from hospitalized patients with healthcare-associated HRE (HA-HRE). In addition, community spread of CRE will be determined.
What is the current status of trial NCT03924934?
This trial is currently completed. The enrollment target is 2,172 participants. The study started on 2019-05-01. Estimated completion is 2024-12-01.
Who is sponsoring clinical trial NCT03924934?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.